Patent Assignment
Reel/Frame 068326/0349
Assignment of Assignor's Interest
Recorded: 2024-08-19
Pages: 5
Assignor
SHIRE HUMAN GENETIC THERAPIES, INC.
Executed: 2021-02-26
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 540-8645, JAPAN
Covered Property
(1)
Purified Arylsulfatase a and Compositions Thereof
Application:
18/804,916 →
Publication:
US 2025/0073320
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.